Diagnostic and treatment precision in fusion technology can only be achieved when human movement at every point-of-care is accounted for.
We believe better health outcomes can only be realized when technological advancements are successfully integrated within current systems and workflows.
Thus, innovation at UC-CARE is sparked by a deep understanding of health practitioner realities. Our solutions are designed consciously, with technological, workflow and business realities held central, in order to meet the needs of, and be easily integrated by, physicians, technicians and patients.
Today UC-CARE’s focus is the development of unique, patented tools that turn blind diagnostics into smart diagnostics that enable focal treatment procedures of prostate diseases.
HEALTH OUTCOME DRIVEN.
UC-CARE USA, CEO
Experienced executive with strong multidisciplinary engineering and marketing skills. Successfully led multi-company, multi-national projects. Former VP of R&D at Celletra, Intel
15 years of experience managing Operations and Supply Chains with Medical Device companies and others. Prior to UC-Care served as COO of Celletra and prior to that as VP of Operations at Galil Medical.
Keren Shapira-Shweizer, PhD
PhD in BioMedical Engineering. Extensive experience in the planning and execution of clinical trials. Prior to UC-Care, Lab Manager at the Technion – Israel Institute of Technology.
Over 40 years of experience as an entrepreneur and founder. Previously Founder & CEO of Galil Medical, President & CEO at Celletra, Executive at Rafael.
UC-CARE USA, Chief Commercial Officer
Thirty-five years of experience in medtech sales, marketing, start-ups (Director Global Marketing, Roche/Medingo; VP Sales and Interim VP Marketing, BioStar/Thermo Fisher), U.S. President, DYSIS Medical and GlycoMark (JV of Toyota Tsusho America)